Spectral lifts revenue

TORONTO – Spectral Diagnostics Inc. raises revenue on increased sales of its Endotoxin Activity Assay, used for measuring endotoxin levels in the blood. For the year ended December 31 2008, the company lifted sales to $3,011,000, a modest increase from $2,993,000 in 2007. However, net income declined throughout the year, culminating in a loss of $1,666,000 or $0.06 a share.

Submit a comment

Please leave your name, which will be used to sign your submission to the SCANsite. Thanks for contributing your thoughts. Come back again. Tony Patterson, Editor & CEO.

© 2006 - 2009 SCAN
INTEGRITY INTELLIGENCE INFORMATION
Site by Citadel Rock
SCAN